
浏览全部资源
扫码关注微信
400038 重庆,陆军军医大学(第三军医大学)第一附属医院全军肝胆外科研究所
[ 郑树国,E-mail: shuguozh@163.com ZHENG Shuguo E-mail: shuguozh@163.com
收稿:2020-12-03,
修回:2021-01-12,
纸质出版:2021-04-15
移动端阅览
孙天歌, 王小军, 曹利, 等. 腹腔镜与开腹肝切除治疗肝尾状叶腔静脉旁部肿瘤的临床研究[J]. 第三军医大学学报, 2021,43(7):640-647.
Tiange SUN, Xiaojun WANG, Li CAO, et al. Laparoscopic versus open liver resection for tumours originating in the paracaval portion of caudate lobe[J]. Journal of Third Military Medical University, 2021, 43(7): 640-647.
孙天歌, 王小军, 曹利, 等. 腹腔镜与开腹肝切除治疗肝尾状叶腔静脉旁部肿瘤的临床研究[J]. 第三军医大学学报, 2021,43(7):640-647. DOI: 10.16016/j.1000-5404.202012027.
Tiange SUN, Xiaojun WANG, Li CAO, et al. Laparoscopic versus open liver resection for tumours originating in the paracaval portion of caudate lobe[J]. Journal of Third Military Medical University, 2021, 43(7): 640-647. DOI: 10.16016/j.1000-5404.202012027.
目的
2
比较腹腔镜肝切除(laparoscopic liver resection
LLR)与开腹肝切除(open liver resection
OLR)治疗腔静脉旁部来源肿瘤的围术期结果和远期疗效
探讨LLR治疗腔静脉旁部来源肿瘤的安全性和可行性。
方法
2
纳入2013年5月至2020年5月我院接受LLR或OLR的腔静脉旁部来源肿瘤患者42例
LLR组、OLR组恶性肿瘤患者中位随访时间分别为27.5、26.0个月。回顾性分析两组患者的围术期和远期疗效。
结果
2
行LLR和行OLR患者各21例。两组均无围手术期死亡
LLR组中1例患者中转开腹。LLR组与OLR组的手术时间、失血量、术中输血率、恶性肿瘤切缘及并发症发生率等差异均无统计学意义。与OLR组比较
LLR组术后进食时间早(
P
=0.042)、住院时间短(
P
=0.008)
术后第1、3、7天血清总胆红素水平低(
P
=0.004、0.010、0.018)。LLR组与OLR组恶性肿瘤患者的1年、3年总生存率差异无统计学意义(100.0%
vs
87.5%
P
=0.292;87.5%
vs
68.8%
P
=0.326)
1年、3年无瘤生存率差异也无统计学意义(62.5%
vs
50.0%
P
=0.488;50.0%
vs
37.5%
P
=0.455)。
结论
2
LLR治疗腔静脉旁部来源肿瘤对于选择性患者安全、可行
同时具有术后进食早、住院时间短的优势。
Objective
2
To compare the perioperative outcomes and long-term efficacy of laparoscopic liver resection (LLR) and open liver resection (OLR) for hepatocellular carcinoma originating in the paracaval portion
and explore the safety and feasibility of LLR in treatment of paracaval-originating tumors.
Methods
2
Forty-two paracaval-originating tumor patients admitted in our hospital from May 2013 to May 2020 were enrolled in this study. The median follow-up time of the patients was 27.5 months in the LLR group and 26.0 months in the OLR group. Perioperative outcomes and long-term effect were analyzed retrospectively.
Results
2
There were 21 patients undergoing LLR and the other 21 OLR
and no perioperative death occurred. One case of the LLR group was converted to OLR during operation. There were no significant differences in operation time
blood loss
intraoperativ
e transfusion rate
resection margin of malignant tumour or postoperative complications. The LLR group obtained earlier postoperative feeding (
P
=0.042)
shorter length of hospital stay (
P
=0.008)
and lower postoperative total bilirubin at 1
3 and 7 d after surgery (
P
=0.004
0.010
0.018) when compared with the OLR group. What's more
no obviously differences were seen in 1- and 3-year overall survival rates (100.0%
vs
87.5%
P
=0.292; 87.5%
vs
68.8%
P
=0.326) or in 1- and 3-year disease-free survival rates (62.5%
vs
50.0%
P
=0.488; 50.0%
vs
37.5%
P
=0.455) between the 2 groups.
Conclusion
2
LLR is safe and feasible for paracaval-originating tumours in selected patients
with the advantages of earlier postoperative feeding and shorter hospital stay.
KUMON M. Anatomical study of the caudate lobe with special reference to portal venous and biliary branches using corrosion liver casts and clinical application[J]. Liver Cancer, 2017, 6(2): 161-170. DOI:10.1159/000454682.
BUELL J F, CHERQUI D, GELLER D A, et al. The international position on laparoscopic liver surgery: The Louisville Statement, 2008[J]. Ann Surg, 2009, 250(5): 825-830. DOI: 10.1097/sla. 0b013e3181b3b2d8.
ISHIZAWA T, GUMBS A A, KOKUDO N, et al. Laparoscopic segmentectomy of the liver: from segment I to Ⅷ[J]. Ann Surg, 2012, 256(6): 959-964. DOI:10.1097/SLA.0b013e31825ffed3.
ARAKI K, KUBO N, WATANABE A, et al. Systematic review of the feasibility and future of laparoscopic liver resection for difficult lesions[J]. Surg Today, 2018, 48(7): 659-666. DOI:10.1007/s00595-017-1607-6.
YOON Y S, HAN H S, CHO J Y, et al. Laparoscopic liver resection for centrally located tumors close to the hilum, major hepatic veins, or inferior vena cava[J]. Surgery, 2013, 153(4): 502-509. DOI: 10.1016/j.surg.2012. 10.004.
DINDO D, DEMARTINES N, CLAVIEN P A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240(2): 205-213. DOI:10.1097/01.sla. 0000133083.54934.ae.
HAN H S, CHO J Y, YOON Y S. Techniques for performing laparoscopic liver resection in various hepatic locations[J]. J Hepato-Biliary-Pancreat Surg, 2009, 16(4): 427-432. DOI:10.1007/s00534-009-0118-2.
NISHIGAKI Y, TOMITA E, HAYASHI H, et al. Efficacy and safety of radiofrequency ablation for hepatocellular carcinoma in the caudate lobe of the liver[J]. Hepatol Res, 2013, 43(5): 467-474. DOI:10.1111/j.1872-034x. 2012.01095.x.
SHIBATA T, MAETANI Y, AMETANI F, et al. Efficacy of nonsurgical treatments for hepatocellular carcinoma in the caudate lobe[J]. Cardiovasc Interv Radiol, 2002, 25(3): 186-192. DOI:10.1007/s00270-001-0111-x.
吐尔洪江·吐逊, 阿卜杜萨拉木·艾尼, 李玉鹏, 等. 非原位肝切除技术安全性、可行性和有效性的系统评价[J]. 中华医学杂志, 2016, 96(28): 2251-2257. DOI:10.3760/cma.j.
TUXUN T, AINI A, LI Y P, et al. Systematic review of feasibility, safety and efficacy of ex situ liver resection and autotransplantation[J]. Natl Med J China, 2016, 96(28): 2251-2257. DOI:10.3760/cma.j.issn.0376-2491. 2016.28.011.
BAKER M A, MALEY W R, NEEDLEMAN L, et al. Ex vivo resection of hepatic neoplasia and autotransplantation: a case report and review of the literature[J]. J Gastrointest Surg, 2015, 19(6): 1169-1176. DOI:10.1007/s11605-015- 2806-3.
GIULIANOTTI P C, BIANCO F M, DASKALAKI D, et al. Robotic liver surgery: technical aspects and review of the literature[J]. Hepatobiliary Surg Nutr, 2016, 5(4): 311-321. DOI:10.21037/hbsn.2015.10.05.
AFANEH C, KLUGER M. Laparoscopic liver resection: lessons at the end of the second decade[J]. Semin Liver Dis, 2013, 33(3): 226-235. DOI:10.1055/s-0033-1351780.
KANEKO T, KANEKO K, SUGIMOTO H, et al. Intrahepatic anastomosis formation between the hepatic veins in the graft liver of the living related liver transplantation: observation by Doppler ultrasonography[J]. Transplantation, 2000, 70(6): 982-985. DOI: 10.1097/ 00007890-200009270-00018.
SUH S W, LEE J M, YOU T, et al. Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence?[J]. Liver Transpl, 2014, 20(7): 784-790. DOI: 10.1002/lt.23877.
YANG C K, TENG A, LEE D Y, et al. Pulmonary complications after major abdominal surgery: National Surgical Quality Improvement Program analysis[J]. J Surg Res, 2015, 198(2): 441-449. DOI:10.1016/j.jss.2015.03.028.
STRATOPOULOS C, SOONAWALLA Z, BROCKMANN J, et al. Central hepatectomy: the golden mean for treating central liver tumors?[J]. Surg Oncol, 2007, 16(2): 99-106. DOI:10.1016/j.suronc.2007.05.002.
MATSUI Y, TERAKAWA N, SATOI S, et al. Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection[J]. Arch Surg Chic Ill, 2007, 142(7): 596-602. DOI:10.1001/archsurg.142.7.596.
SAKAMOTO Y, NARA S, HATA S, et al. Prognosis of patients undergoing hepatectomy for solitary hepatocellular carcinoma originating in the caudate lobe[J]. Surgery, 2011, 150(5): 959-967. DOI:10.1016/j.surg.2011.03.005.
ZERVANTONAKIS I K, HUGHES-ALFORD S K, CHAREST J L, et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function[J]. Proc Natl Acad Sci USA, 2012, 109(34): 13515-13520. DOI: 10.1073/pnas. 1210182109.
LOCKWOOD D S R, YEADON T M, CLOUSTON A D, et al. Tumor progression in hepatocellular carcinoma: relationship with tumor stroma and parenchymal disease[J]. J Gastroenterol Hepatol, 2003, 18(6): 666-672. DOI:10.1046/j.1440-1746.2003.03018.x.
NG I O, LAI E C, FAN S T, et al. Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients[J]. Cancer, 1995, 76(12): 2443-2448. DOI:10.1002/1097-0142(19951215)76: 122443:aid-cncr2820761207>3.0.co;2-f.
ERSTAD D J, TANABE K K. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma[J]. Ann Surg Oncol, 2019, 26(5): 1474-1493. DOI: 10.1245/s10434-019-07227-9.
YU W B, WANG W H, RONG W Q, et al. Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin(1 cm): a prospective randomized study[J]. J Am Coll Surg, 2014, 218(3): 381-392. DOI:10.1016/j.jamcollsurg.2013.11.030.
QIU J, WU H, BAI Y, et al. Mesohepatectomy for centrally located liver tumours[J]. Br J Surg, 2013, 100(12): 1620-1626. DOI:10.1002/bjs.9286
FANG C H, AN J, BRUNO A, et al. Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases[J]. Hepatol Int, 2020, 14(4): 437-453. DOI:10.1007/s12072-020-10052-y.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621